Savara (SVRA) announced that it has completed submission of the BLA to the FDA for MOLBREEVI as a treatment for aPAP. “Submission of the BLA ...
During one of the final manoeuvres, the aircraft experienced a sudden loss of altitude and entered a steep dive.' ...